Structural changes in the dorsolateral prefrontal cortex following a randomized clinical trial of virtual reality–based cognitive remediation in mood and schizophrenia spectrum disorders
Publication date: 20 December 2026 Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 151 Author(s): Julian Macoveanu, Tabe Olde, Andreas Elleby Jespersen, Anders Lumbye, Maj Vinberg, Louise Birkedal Glenthøj, Merete Nordentoft, Anjali Sankar, Gitte Moos Knudsen, Kamilla Woznica Miskowiak
Structural changes in the dorsolateral prefrontal cortex following a randomized clinical trial of virtual reality–based cognitive remediation in mood and schizophrenia spectrum disorders. // Progress in Neuro-Psychopharmacology & Biological Psychiatry. – URL: https://www.sciencedirect.com/science/article/pii/S0278584626003970?dgcid=rss_sd_all
Structural changes in the dorsolateral prefrontal cortex following a randomized clinical trial of virtual reality–based cognitive remediation in mood and schizophrenia spectrum disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. https://www.sciencedirect.com/science/article/pii/S0278584626003970?dgcid=rss_sd_all
“Structural changes in the dorsolateral prefrontal cortex following a randomized clinical trial of virtual reality–based cognitive remediation in mood and schizophrenia spectrum disorders.” Progress in Neuro-Psychopharmacology & Biological Psychiatry.
@article{article62873,
title = {Structural changes in the dorsolateral prefrontal cortex following a randomized clinical trial of virtual reality–based cognitive remediation in mood and schizophrenia spectrum disorders},
journal = {Progress in Neuro-Psychopharmacology \& Biological Psychiatry},
url = {https://www.sciencedirect.com/science/article/pii/S0278584626003970?dgcid=rss_sd_all}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...